684 related articles for article (PubMed ID: 19056840)
61. How best is to discontinue postmenopausal hormone therapy: immediate or tapered?
Aslan E; Bagis T; Kilicdag EB; Tarim E; Erkanli S; Kuscu E
Maturitas; 2007 Jan; 56(1):78-83. PubMed ID: 17046182
[TBL] [Abstract][Full Text] [Related]
62. Management of Menopausal Symptoms for Women Who Are at High Risk of Thrombosis.
Pinkerton JV; James AH
Clin Obstet Gynecol; 2018 Jun; 61(2):260-268. PubMed ID: 29419532
[TBL] [Abstract][Full Text] [Related]
63. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
Lynch C
J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
[TBL] [Abstract][Full Text] [Related]
64. Progress and prospects in treating postmenopausal vaginal atrophy.
Winneker RC; Harris HA
Clin Pharmacol Ther; 2011 Jan; 89(1):129-32. PubMed ID: 20944561
[TBL] [Abstract][Full Text] [Related]
65. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
66. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
Archer DF
Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
[TBL] [Abstract][Full Text] [Related]
67. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
Abraham L; Pinkerton JV; Messig M; Ryan KA; Komm BS; Mirkin S
Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362
[TBL] [Abstract][Full Text] [Related]
68. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
Mirkin S; Ryan KA; Chandran AB; Komm BS
Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
[TBL] [Abstract][Full Text] [Related]
69. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach.
Hickey M; Saunders CM; Stuckey BG
Lancet Oncol; 2005 Sep; 6(9):687-95. PubMed ID: 16129369
[TBL] [Abstract][Full Text] [Related]
70. Menopausal Hormone Therapy and the Role of Estrogen.
Stuenkel CA
Clin Obstet Gynecol; 2021 Dec; 64(4):757-771. PubMed ID: 34231526
[TBL] [Abstract][Full Text] [Related]
71. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
[TBL] [Abstract][Full Text] [Related]
72. New therapeutic approaches for hot flashes in women.
Stearns V; Loprinzi CL
J Support Oncol; 2003; 1(1):11-21; discussion 14-5, 19-21. PubMed ID: 15352639
[TBL] [Abstract][Full Text] [Related]
73. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
Woodis CB
J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
[TBL] [Abstract][Full Text] [Related]
74. Should symptomatic menopausal women be offered hormone therapy?
Lobo RA; Bélisle S; Creasman WT; Frankel NR; Goodman NE; Hall JE; Ivey SL; Kingsberg S; Langer R; Lehman R; McArthur DB; Montgomery-Rice V; Notelovitz M; Packin GS; Rebar RW; Rousseau M; Schenken RS; Schneider DL; Sherif K; Wysocki S
MedGenMed; 2006; 8(2):1 p preceding 35. PubMed ID: 17048337
[TBL] [Abstract][Full Text] [Related]
75. Menopause.
Carter AE; Merriam S
Med Clin North Am; 2023 Mar; 107(2):199-212. PubMed ID: 36759091
[TBL] [Abstract][Full Text] [Related]
76. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
77. Assessment and treatment of hot flushes and menopausal mood disturbance.
Joffe H; Soares CN; Cohen LS
Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
[TBL] [Abstract][Full Text] [Related]
78. The menopause revisited.
Samsioe G
Int J Gynaecol Obstet; 1995 Oct; 51(1):1-13. PubMed ID: 8582512
[TBL] [Abstract][Full Text] [Related]
79. Menopause.
Potter B; Schrager S; Dalby J; Torell E; Hampton A
Prim Care; 2018 Dec; 45(4):625-641. PubMed ID: 30401346
[TBL] [Abstract][Full Text] [Related]
80. The 2017 hormone therapy position statement of The North American Menopause Society.
Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
